A research team in Japan has developed an efficient and minimally invasive cancer detection device that uses high-performance zinc oxide nanowires to selectively capture extracellular vesicles (EVs) ...
KLOSTERNEUBURG, Austria & ROCKVILLE, Md.--(BUSINESS WIRE)--VALANX Biotech (VALANX), a biotech company developing novel technology for site-specific protein conjugation in drug and diagnostics ...
Treatment-related toxicities of antibody-drug conjugates in breast cancer: A Bayesian network meta-analysis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does ...
Primrose Bio will supply its industry-leading carrier protein, PeliCRM197®, for vaccine developmentIntravacc has knowhow in vaccine conjugation ...
CD39 expression as a predictive biomarker for neoadjuvant treatment in muscle-invasive bladder cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium. This ...
Researchers from MD Anderson Cancer Center recently presented the discovery and preclinical evaluation of LLO-CD47, a novel protein-antibody conjugate linking anti-CD47 to Listeriolysin O (LLO), a ...
Iron oxide-incorporated conjugated polymer nanoparticles, also known as conjugated polymer nanoparticles (CPNs), are highly fluorescent particles composed of a semiconductor light-emitting polymer ...
Variations in conjugation chemistry conditions can lead to differences in stoichiometries and, ultimately, impact drug safety and efficacy. Therefore, there is an urgent need to measure multiple ...
Researchers from Elpiscience Biopharmaceuticals Inc. discussed the discovery and preclinical characterization of a novel NKG2A antibody-IL-2 mutant fusion protein – ES-015.129 – being developed as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results